Literature DB >> 18958525

An epigenetic aberration increased in intergenic regions of cloned mice.

Hiromi Nishida1, Shinji Kondo, Takahiro Suzuki, Yuki Tsujimura, Shunsuke Komatsu, Teruhiko Wakayama, Yoshihide Hayashizaki.   

Abstract

The causes of frequent abnormal phenotypes and low success rate in mammalian cloning are poorly understood. Although epigenetic aberration is suspected to be a cause, its connection to the phenotypes has yet to be investigated. To measure the level of reprogramming of an epigenetic mark, acetylation at lysine 9 of histone H3 (H3K9Ac), in cloned mice, we examined its conservation between two cloned mice derived from distinct cell nuclei and their natural donors by utilizing whole-genome tiling arrays and quantitative PCR. Pairwise comparison of the H3K9Ac enrichment profile between the four mice revealed that H3K9Ac is less conserved in intergenic regions than in promoter regions of protein-coding genes. Intriguingly, the variation of H3K9Ac enrichment in intergenic regions is the most prominent in comparison of the two clones, possibly reflecting an additive effect of aberrant reprogramming of this epigenetic information occurring specifically in each of the two clones.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18958525     DOI: 10.1007/s00335-008-9146-5

Source DB:  PubMed          Journal:  Mamm Genome        ISSN: 0938-8990            Impact factor:   2.957


  25 in total

1.  The health profile of cloned animals.

Authors:  Jose B Cibelli; Keith H Campbell; George E Seidel; Michael D West; Robert P Lanza
Journal:  Nat Biotechnol       Date:  2002-01       Impact factor: 54.908

2.  Large-scale transcriptional activity in chromosomes 21 and 22.

Authors:  Philipp Kapranov; Simon E Cawley; Jorg Drenkow; Stefan Bekiranov; Robert L Strausberg; Stephen P A Fodor; Thomas R Gingeras
Journal:  Science       Date:  2002-05-03       Impact factor: 47.728

3.  BLAT--the BLAST-like alignment tool.

Authors:  W James Kent
Journal:  Genome Res       Date:  2002-04       Impact factor: 9.043

4.  Somatic cell nuclear transfer.

Authors:  I Wilmut; N Beaujean; P A de Sousa; A Dinnyes; T J King; L A Paterson; D N Wells; L E Young
Journal:  Nature       Date:  2002-10-10       Impact factor: 49.962

5.  Abnormal gene expression in cloned mice derived from embryonic stem cell and cumulus cell nuclei.

Authors:  David Humpherys; Kevin Eggan; Hidenori Akutsu; Adam Friedman; Konrad Hochedlinger; Ryuzo Yanagimachi; Eric S Lander; Todd R Golub; Rudolf Jaenisch
Journal:  Proc Natl Acad Sci U S A       Date:  2002-09-16       Impact factor: 11.205

6.  On the road to therapeutic cloning.

Authors:  Teruhiko Wakayama
Journal:  Nat Biotechnol       Date:  2004-04       Impact factor: 54.908

7.  Epigenetic instability in ES cells and cloned mice.

Authors:  D Humpherys; K Eggan; H Akutsu; K Hochedlinger; W M Rideout ; D Biniszkiewicz; R Yanagimachi; R Jaenisch
Journal:  Science       Date:  2001-07-06       Impact factor: 47.728

8.  Conservation of methylation reprogramming in mammalian development: aberrant reprogramming in cloned embryos.

Authors:  W Dean; F Santos; M Stojkovic; V Zakhartchenko; J Walter; E Wolf; W Reik
Journal:  Proc Natl Acad Sci U S A       Date:  2001-11-20       Impact factor: 11.205

9.  The transcriptional landscape of the mammalian genome.

Authors:  P Carninci; T Kasukawa; S Katayama; J Gough; M C Frith; N Maeda; R Oyama; T Ravasi; B Lenhard; C Wells; R Kodzius; K Shimokawa; V B Bajic; S E Brenner; S Batalov; A R R Forrest; M Zavolan; M J Davis; L G Wilming; V Aidinis; J E Allen; A Ambesi-Impiombato; R Apweiler; R N Aturaliya; T L Bailey; M Bansal; L Baxter; K W Beisel; T Bersano; H Bono; A M Chalk; K P Chiu; V Choudhary; A Christoffels; D R Clutterbuck; M L Crowe; E Dalla; B P Dalrymple; B de Bono; G Della Gatta; D di Bernardo; T Down; P Engstrom; M Fagiolini; G Faulkner; C F Fletcher; T Fukushima; M Furuno; S Futaki; M Gariboldi; P Georgii-Hemming; T R Gingeras; T Gojobori; R E Green; S Gustincich; M Harbers; Y Hayashi; T K Hensch; N Hirokawa; D Hill; L Huminiecki; M Iacono; K Ikeo; A Iwama; T Ishikawa; M Jakt; A Kanapin; M Katoh; Y Kawasawa; J Kelso; H Kitamura; H Kitano; G Kollias; S P T Krishnan; A Kruger; S K Kummerfeld; I V Kurochkin; L F Lareau; D Lazarevic; L Lipovich; J Liu; S Liuni; S McWilliam; M Madan Babu; M Madera; L Marchionni; H Matsuda; S Matsuzawa; H Miki; F Mignone; S Miyake; K Morris; S Mottagui-Tabar; N Mulder; N Nakano; H Nakauchi; P Ng; R Nilsson; S Nishiguchi; S Nishikawa; F Nori; O Ohara; Y Okazaki; V Orlando; K C Pang; W J Pavan; G Pavesi; G Pesole; N Petrovsky; S Piazza; J Reed; J F Reid; B Z Ring; M Ringwald; B Rost; Y Ruan; S L Salzberg; A Sandelin; C Schneider; C Schönbach; K Sekiguchi; C A M Semple; S Seno; L Sessa; Y Sheng; Y Shibata; H Shimada; K Shimada; D Silva; B Sinclair; S Sperling; E Stupka; K Sugiura; R Sultana; Y Takenaka; K Taki; K Tammoja; S L Tan; S Tang; M S Taylor; J Tegner; S A Teichmann; H R Ueda; E van Nimwegen; R Verardo; C L Wei; K Yagi; H Yamanishi; E Zabarovsky; S Zhu; A Zimmer; W Hide; C Bult; S M Grimmond; R D Teasdale; E T Liu; V Brusic; J Quackenbush; C Wahlestedt; J S Mattick; D A Hume; C Kai; D Sasaki; Y Tomaru; S Fukuda; M Kanamori-Katayama; M Suzuki; J Aoki; T Arakawa; J Iida; K Imamura; M Itoh; T Kato; H Kawaji; N Kawagashira; T Kawashima; M Kojima; S Kondo; H Konno; K Nakano; N Ninomiya; T Nishio; M Okada; C Plessy; K Shibata; T Shiraki; S Suzuki; M Tagami; K Waki; A Watahiki; Y Okamura-Oho; H Suzuki; J Kawai; Y Hayashizaki
Journal:  Science       Date:  2005-09-02       Impact factor: 47.728

10.  Genome-wide analysis of abnormal H3K9 acetylation in cloned mice.

Authors:  Takahiro Suzuki; Shinji Kondo; Teruhiko Wakayama; Paul E Cizdziel; Yoshihide Hayashizaki
Journal:  PLoS One       Date:  2008-04-09       Impact factor: 3.240

View more
  1 in total

1.  Comparative studies of genome-wide maps of nucleosomes between deletion mutants of elp3 and hos2 genes of Saccharomyces cerevisiae.

Authors:  Takashi Matsumoto; Choong-Soo Yun; Hirofumi Yoshikawa; Hiromi Nishida
Journal:  PLoS One       Date:  2011-01-28       Impact factor: 3.240

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.